Industrial scale production of plasmid DNA for vaccine and gene therapy: plasmid design, production, and purification
- 27 October 2003
- journal article
- review article
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 33 (7), 865-883
- https://doi.org/10.1016/s0141-0229(03)00205-9
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifsGene Therapy, 2001
- WHO Guidelines for Assuring the Quality of DNA VaccinesBiologicals, 1998
- RNases in ColE1 DNA metabolismMolecular Biology Reports, 1996
- Synthesis of Proteins in Escherichia coli is Limited by the Concentration of Free RibosomesJournal of Molecular Biology, 1993
- The biocontainment of a high speed disc bowl centrifugeBioprocess and Biosystems Engineering, 1992
- Batch and fed batch cultivations for the temperature induced production of a recombinant protein inEscherichia coliBiotechnology Letters, 1991
- Escherichia coli growth and plasmid copy numbers in continuous cultivationsBiotechnology Letters, 1989
- Physiological constraints in increasing biomass concentration ofEscherichia coli B in fed-batch cultureBiotechnology Letters, 1987
- PRODUCTION OF HUMAN ALPHA CONSENSUS INTERFERON IN RECOMBINANT ESCHERICHIA COLIChemical Engineering Communications, 1986
- Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectorsGene, 1985